What makes you pause, stare, admire? What leaves you in awe? Your reverence reveals what you love and who you are. What amazes us speaks. The Gospels whisper secrets about what astonishes men. Their pages gasp with wonder, fill with emojis, punctuate with exclamation points. We get to see men and women stare wide-eyed, stunned…
We are all interim. I have often reminded myself of this fact in recent years. When I started seminary, I also applied for a ministry assistant position at a local church. Their youth pastor had left earlier in the year; they asked me to interview for the leadership role in the ministry as the “Interim.”…
Summary: Researchers at the University of Arizona are exploring a novel, nondrug treatment for insomnia among military personnel using magnetic brain stimulation. Supported by a $3 million grant from the Department of Defense, the study led by William “Scott” Killgore aims to reduce excessive brain activity that interferes with sleep by targeting the default mode…
Summary: A large-scale study analyzing over 13 million hours of light exposure data from 89,000 people has found that exposure to high levels of night light and limited daylight disrupts circadian rhythms, increasing mortality risk. The study, published in Proceedings of the National Academy of Sciences, underscores the importance of day and night light patterns…
Summary: Sleep Doctor has appointed David Kopp as CEO, a move that aims to accelerate its direct-to-consumer business expansion, with plans to enhance accessibility to sleep health resources and at-home testing. Kopp, who replaces co-founder Patrick Gavin, brings a background in consumer healthcare and digital media to the role. Key Takeaways: New Leadership for Growth:…
Summary: A US court upheld the FDA’s approval of Avadel Pharmaceuticals’ Lumryz, a once-nightly oxybate for narcolepsy, rejecting Jazz Pharmaceuticals’ challenge on orphan status and clinical superiority grounds. The ruling confirms Lumryz’s orphan drug exclusivity based on its clinical advantages over Jazz’s twice-nightly oxybate. Key Takeaways: Court Upholds FDA Approval: The US court ruled in…
Summary: ŌURA has acquired Sparta Science to enhance its Oura Teams platform, aiming to deliver scalable, data-driven health insights for enterprise clients, including healthcare and government organizations. Leveraging Sparta Science’s Trinsic platform, ŌURA will integrate multiple data sources to support personalized health tracking and population-level analytics, with added technical expertise from former Sparta Science team…
Summary: Ahead of Drowsy Driving Prevention Week, the National Sleep Foundation’s survey reveals that while 70% of Americans avoid driving after drinking, only 40% take similar precautions when sleep-deprived. Drowsy driving, which causes thousands of crashes and fatalities annually, is linked to impaired driving abilities comparable to drunk driving. Key Takeaways: Low Awareness of Drowsy…
Summary: At the 37th annual Psych Congress, Jazz Pharmaceuticals presented results from the phase 4 DUET trial on low-sodium Xywav, showing its effectiveness in treating excessive daytime sleepiness and improving sleep outcomes for adults with narcolepsy and idiopathic hypersomnia. Findings indicated notable improvements in polysomnography measures like nighttime awakenings and sleep stage stability, reinforcing Xywav’s…
How many people do you know who have left a church for bad reasons? The music wasn’t their kind of music. The sermons weren’t short or engaging enough. The children’s programming lacked the entertainment factor of other churches. The church was a little too big (for those looking for more attention) or a little too…